AI brief of an SEC Form 8-K · Gibraltar Industries (ROCK)

Gibraltar's preliminary 2025 sales and EPS fall below previous guidance ranges

Negative Impact 4 of 5 earnings Written later

Gibraltar Industries reported preliminary, unaudited 2025 results that came in below its previous guidance for both net sales and EPS. Full-year 2025 net sales are estimated at $1,128 million to $1,138 million, versus prior guidance of $1,150 million to $1,175 million, and GAAP EPS is estimated at $3.21 to $3.26, versus prior guidance of $3.67 to $3.77. Shareholders should note the figures may change after audit procedures, and management points to a $115 million cash balance and the pending Omnimax acquisition.

Key points

  • 2025 net sales estimate of $1,128 million to $1,138 million, below previous guidance of $1,150 million to $1,175 million
  • 2025 GAAP EPS estimate of $3.21 to $3.26, below previous guidance of $3.67 to $3.77 and 2024 GAAP EPS of $4.58
  • Fourth-quarter net sales estimate of $261 million to $271 million, below previous guidance of $283 million to $308 million
  • Omnimax acquisition now expected to close in the first quarter of 2026; cash balance above $115 million

The filing

CompanyGibraltar Industries (ROCK)
Form8-K, current report
Filed with the SECJan 21, 2026, 7:47 AM ET
Accession number0000912562-26-000013

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 21, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.